NUS
NYSE · Consumer products
Nu Skin Enterprises Inc - A
$4.53
-0.46 (-9.22%)
Financial Highlights (FY 2026)
Revenue
1.40B
Net Income
150.58M
Gross Margin
69.4%
Profit Margin
10.8%
Rev Growth
-12.6%
D/E Ratio
0.29
Revenue & Net Income
Margin Trends
| FY 2026 | FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|---|
| Gross Margin | 69.4% | 69.4% | 56.7% | 56.7% |
| Operating Margin | 16.3% | 14.7% | 9.3% | 8.2% |
| Profit Margin | 10.8% | 10.3% | 7.2% | 8.8% |
Income Statement
| FY 2026 | FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|---|
| Revenue | 1.40B | 1.60B | 239.11M | 240.56M |
| Gross Profit | 969.49M | 1.11B | 135.59M | 136.41M |
| Operating Income | 227.40M | 234.22M | 22.12M | 19.66M |
| Net Income | 150.58M | 155.10M | 17.26M | 21.16M |
| Gross Margin | 69.4% | 69.4% | 56.7% | 56.7% |
| Operating Margin | 16.3% | 14.7% | 9.3% | 8.2% |
| Profit Margin | 10.8% | 10.3% | 7.2% | 8.8% |
| Rev Growth | -12.6% | -12.6% | +7.9% | +9.5% |
Balance Sheet
| FY 2026 | FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|---|
| Total Debt | 23.84M | 23.84M | 116.04M | 131.43M |
| Total Equity | 83.25M | 83.25M | 382.53M | 420.07M |
| D/E Ratio | 0.29 | 0.29 | 0.30 | 0.31 |
Cash Flow
| FY 2026 | FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|---|
| EBITDA | 276.52M | 300.63M | 32.19M | 32.46M |
| Free Cash Flow | — | — | 8.63M | 9.23M |